Armistice Capital, Llc Avalo Therapeutics, Inc. (AVTX) insider trading activity
Armistice Capital, LLC is > 10% Shareholder of Avalo Therapeutics, Inc.. Currently has a direct ownership of 39.1 Million shares of AVTX, which is worth approximately $382 Million. The most recent transaction as insider was on May 18, 2021, when has been sold 22,000 shares (Common Stock) at a price of $2.33 per share, resulting in proceeds of $51,260. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
39.1M
0%
3M change
0%
12M change
Total Value Held
$382 Million
ARMISTICE CAPITAL, LLC Transaction History
Also insider at
ACL
Armistice Capital, LLC
> 10% Shareholder
New York, NY